Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies.

H. C. Stevenson, H. G. Klein

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)559-565
Number of pages7
JournalProgress in Clinical and Biological Research
Volume337
StatePublished - 1990
Externally publishedYes

Fingerprint

Immunologic Cytotoxicity
Combined Modality Therapy
Blood Component Removal
Passive Immunization
Immunologic Factors
Clinical Protocols
Antineoplastic Agents
Immunotherapy
Leukocytes
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{18e6f025acc5469fa757cc2b455669e7,
title = "Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies.",
author = "Stevenson, {H. C.} and Klein, {H. G.}",
year = "1990",
language = "English (US)",
volume = "337",
pages = "559--565",
journal = "Progress in Clinical and Biological Research",
issn = "0361-7742",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets

T2 - strategies for rational design of apheresis-based cancer immunotherapies.

AU - Stevenson, H. C.

AU - Klein, H. G.

PY - 1990

Y1 - 1990

UR - http://www.scopus.com/inward/record.url?scp=0025035145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025035145&partnerID=8YFLogxK

M3 - Article

C2 - 2353018

AN - SCOPUS:0025035145

VL - 337

SP - 559

EP - 565

JO - Progress in Clinical and Biological Research

JF - Progress in Clinical and Biological Research

SN - 0361-7742

ER -